- Home
- GNLX vs SBSI Comparison
GNLX vs SBSI Comparison
Compare GNLX & SBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- SBSI
- Stock Information
- Founded
- GNLX 2001
- SBSI 1960
- Country
- GNLX United States
- SBSI United States
- Employees
- GNLX N/A
- SBSI N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- SBSI Major Banks
- Sector
- GNLX Health Care
- SBSI Finance
- Exchange
- GNLX Nasdaq
- SBSI Nasdaq
- Market Cap
- GNLX 103.6M
- SBSI N/A
- IPO Year
- GNLX 2023
- SBSI N/A
- Fundamental
- Price
- GNLX $2.27
- SBSI $32.26
- Analyst Decision
- GNLX Strong Buy
- SBSI
- Analyst Count
- GNLX 4
- SBSI 0
- Target Price
- GNLX $18.25
- SBSI N/A
- AVG Volume (30 Days)
- GNLX 142.7K
- SBSI 132.3K
- Earning Date
- GNLX 11-14-2024
- SBSI 01-24-2025
- Dividend Yield
- GNLX N/A
- SBSI 4.46%
- EPS Growth
- GNLX N/A
- SBSI N/A
- EPS
- GNLX N/A
- SBSI 2.78
- Revenue
- GNLX $8,000.00
- SBSI $244,615,000.00
- Revenue This Year
- GNLX N/A
- SBSI N/A
- Revenue Next Year
- GNLX N/A
- SBSI $2.43
- P/E Ratio
- GNLX N/A
- SBSI $11.62
- Revenue Growth
- GNLX N/A
- SBSI N/A
- 52 Week Low
- GNLX $1.60
- SBSI $25.30
- 52 Week High
- GNLX $16.60
- SBSI $38.00
- Technical
- Relative Strength Index (RSI)
- GNLX 38.68
- SBSI 32.76
- Support Level
- GNLX $2.13
- SBSI $32.01
- Resistance Level
- GNLX $2.80
- SBSI $35.77
- Average True Range (ATR)
- GNLX 0.20
- SBSI 0.93
- MACD
- GNLX -0.04
- SBSI -0.39
- Stochastic Oscillator
- GNLX 14.21
- SBSI 6.28
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.